The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Orion; Pfizer; Puma Biotechnology; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Puma Biotechnology
Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.
 
Cristina Saura
Consulting or Advisory Role - AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Genomic Health; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Synthon
Research Funding - AstraZeneca (Inst); Genentech (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genomic Health; Genomic Health; Novartis; Pfizer; Puma Biotechnology; Roche; Roche
 
Mafalda Oliveira
Honoraria - Roche
Consulting or Advisory Role - GlaxoSmithKline; Puma Biotechnology; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Celldex (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Novartis (Inst); Philips Healthcare (Inst); Piqur (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - GP Pharm; Grunenthal; Novartis; Pierre Fabre; Roche
 
Yin-Hsun Feng
No Relationships to Disclose
 
Ming-Shen Dai
No Relationships to Disclose
 
Sara A. Hurvitz
Research Funding - Ambryx (Inst); Amgen (Inst); Bayer (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; OBI Pharma
 
Sung-Bae Kim
Consulting or Advisory Role - Enzychem Lifesciences (Inst); Lilly (Inst); Novartis (Inst); Odonate Therapeutics (Inst)
Research Funding - Dongkook Pharma (Inst); Genzyme (Inst); Novartis (Inst)
 
Beverly Moy
Honoraria - Medscape; Motus Gi (I)
Research Funding - Puma Biotechnology (Inst)
 
Suzette Delaloge
No Relationships to Disclose
 
William John Gradishar
Consulting or Advisory Role - Genentech/Roche
 
Norikazu Masuda
Leadership - Japan Breast Cancer Research Group
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Lilly Japan; Pfizer; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
 
Marketa Palacova
Honoraria - Pfizer
 
Maureen E. Trudeau
Stock and Other Ownership Interests - RNA Diagnostics
Consulting or Advisory Role - RNA Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Genomic Health (Inst); Novartis (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Johanna Mattson
Honoraria - Amgen; Pfizer; Takeda
Consulting or Advisory Role - Orion; Pfizer; Roche
Expert Testimony - Pfizer
 
Yoon Sim Yap
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Pfizer
 
Richard Bryce
Employment - Puma Biotechnology
Leadership - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
Travel, Accommodations, Expenses - Puma Biotechnology
 
Bin Yao
Employment - Puma Biotechnology
 
Judith D. Bebchuk
Employment - Puma Biotechnology
 
Kiana Keyvanjah
Employment - Puma Biotechnology
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Bayer; Bioarray Therapeutics; bioTheranostics; Celgene; Eisai; Genentech/Roche; Genomic Health; Lilly; Merck; Myriad Pharmaceuticals; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology